Helping patients find the pancreatic cancer
resources they deserve
How do we help pancreatic cancer patients?
Massive Bio offers an independent cancer treatment analysis as well as free clinical trial matching for pancreatic cancer patients. Our patient advocates work closely with patients to gather information on their current medical status, and then will provide a list of options from available cancer clinical trials close to your home.
We can also provide a comprehensive case analysis through our Virtual Tumor Board from cancer specialists. The Virtual Tumor Board (VTB) is comprised of highly specialized oncologists from nationally-recognized Cancer Centers of Excellence. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.
There are approximately 321 clinical trials for pancreatic cancer that are currently recruiting patients in the United States right now. With such an extensive list, many of them could be beneficial for you. Our team of patient advocates, who are oncology nurses, and our artificial intelligence-based clinical trial matching system will find the best option for you.
Active clinical trials for which you may qualify:
Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PDAC (Trybeca-1)
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer
With just a few clicks, you can see your clinical trial matches now. Click here to use our advanced clinical trial match tool.
Pancreatic Cancer Facts
There will be over 56,000 new pancreatic cancer cases this year which makes up only slightly more than 3% of all cancer cases, making it the 11th most popular cancer type today. Despite being 11th in number of cases, this cancer type is 3rd in cancer deaths in the United States. Over 89% of pancreatic cancer patients are at least 55 years of age, making it very rare in the case of adults.
Five treatment methods are often utilized with pancreatic cancer patients. They include:
Because pancreatic cancer is not associated with any symptoms until it has spread to other parts of the body, it is difficult to detect in its early stages. With no definitive test to detect this cancer, patients often turn to clinical trials to see if they have any mutations or genes that are related to others with pancreatic cancer.
The number of pancreatic cancer cases and number of deaths has increased slightly since 1975. Despite the increase in cases, the five-year survival rate has gone from 3% to nearly 9%. If the pancreatic cancer is discovered while still localized and hasn’t metastasized, the five-year survival rate sees a large jump to 37%.
Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.